141 related articles for article (PubMed ID: 30624275)
1. Heterogeneous Uptake of 18F-FDG and 68Ga-PSMA-11 in Hepatocellular Carcinoma.
Perez PM; Flavell RR; Kelley RK; Umetsu S; Behr SC
Clin Nucl Med; 2019 Mar; 44(3):e133-e135. PubMed ID: 30624275
[TBL] [Abstract][Full Text] [Related]
2. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT.
Kuyumcu S; Has-Simsek D; Iliaz R; Sanli Y; Buyukkaya F; Akyuz F; Turkmen C
Clin Nucl Med; 2019 Sep; 44(9):702-706. PubMed ID: 31348076
[TBL] [Abstract][Full Text] [Related]
3. Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging.
Erhamamci S; Aslan N
Clin Nucl Med; 2020 Mar; 45(3):e176-e177. PubMed ID: 31977478
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
Jochumsen MR; Gormsen LC; Nielsen GL
Clin Nucl Med; 2018 Feb; 43(2):117-119. PubMed ID: 29261620
[TBL] [Abstract][Full Text] [Related]
6. 68Ga-PSMA Uptake in Combined Hepatocellular Cholangiocarcinoma With Skeletal Metastases.
Alipour R; Gupta S; Trethewey S
Clin Nucl Med; 2017 Oct; 42(10):e452-e453. PubMed ID: 28806238
[TBL] [Abstract][Full Text] [Related]
7. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
[TBL] [Abstract][Full Text] [Related]
8. The uptake exploration of 68Ga-labeled NGR in well-differentiated hepatocellular carcinoma xenografts: Indication for the new clinical translational of a tracer based on NGR.
Gao Y; Wang Z; Ma X; Ma W; Zhao M; Fu T; Li G; Wang S; Wang Z; Yang W; Kang F; Wang J
Oncol Rep; 2017 Nov; 38(5):2859-2866. PubMed ID: 28901442
[TBL] [Abstract][Full Text] [Related]
9. Incidental Detection of Metastatic Malignant Melanoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT Imaging: Correlative Imaging With FDG PET/CT and Review of the Literature.
Anconina R; Hod N; Levin D; Ezroh Kazap D; Lantsberg S
Clin Nucl Med; 2018 Mar; 43(3):204-206. PubMed ID: 29293137
[TBL] [Abstract][Full Text] [Related]
10. Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
Weitzer F; Nazerani-Hooshmand T; Aigner RM; Pernthaler B
Clin Nucl Med; 2021 Jul; 46(7):e358-e359. PubMed ID: 34081054
[TBL] [Abstract][Full Text] [Related]
11. Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
Perez PM; Hope TA; Behr SC; van Zante A; Small EJ; Flavell RR
Clin Nucl Med; 2019 Jan; 44(1):e28-e32. PubMed ID: 30394930
[TBL] [Abstract][Full Text] [Related]
12. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
Civan C; Isik EG; Simsek DH
Clin Nucl Med; 2021 Apr; 46(4):e212-e213. PubMed ID: 33156050
[TBL] [Abstract][Full Text] [Related]
13. Occult Bone Metastases From Hepatocellular Carcinoma Detected on 68Ga-PMSA PET/CT.
Usmani S; Rasheed R; Al Kandari F; Ahmed N
Clin Nucl Med; 2021 Aug; 46(8):661-663. PubMed ID: 33512948
[TBL] [Abstract][Full Text] [Related]
14. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
Lee M; Ko H; Yun M
Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847
[TBL] [Abstract][Full Text] [Related]
15. 68Ga-PSMA Uptake in Angiolipoma.
Dekker I; van der Leest M; van Rijk MC; Gerritsen WR; Arens AIJ
Clin Nucl Med; 2018 Oct; 43(10):757-758. PubMed ID: 30153142
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
Acar E; Kaya GÇ
Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
[TBL] [Abstract][Full Text] [Related]
17. Arterial Phase 18F-Fluorocholine PET/CT in Hepatocellular Carcinoma.
Legendre A; Collet G; Lahousse H; Aziz AL; Petyt G
Clin Nucl Med; 2019 Feb; 44(2):133-136. PubMed ID: 30516677
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-PSMA Uptake in Hepatocellular Carcinoma.
Taneja S; Taneja R; Kashyap V; Jha A; Jena A
Clin Nucl Med; 2017 Jan; 42(1):e69-e70. PubMed ID: 27607177
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Metastasis From Hepatocellular Carcinoma Visualized by 18F-FDG PET/CT Imaging.
Yin H; Luo R; Xiu Y; Hu Y; Shi H
Clin Nucl Med; 2018 Dec; 43(12):e455-e457. PubMed ID: 30247212
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA
Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
